RAB7A and melanoma: Our data provide a new concept of how a small GTPase, Rab7a affects cancer/melanoma hallmarks by controlling the activity of the endolysosomal cation channel TPC2 with effects on GSK3β degradation and thus β-Catenin and MITF levels.